Yuyu Pharma, Inc. (000220) Stock Statistics & Valuation Metrics

Yuyu Pharma, Inc. has a market cap or net worth of ₩51.63B. The enterprise value is ―.

Yuyu Pharma, Inc. has 15,747,462 shares outstanding. The number of shares has decreased by -2.65% in one year.

Yuyu Pharma, Inc.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 6.02%.

The current PE Ratio of Yuyu Pharma, Inc. is 6.8. Yuyu Pharma, Inc.’s PEG ratio is 1.80.

In the last 12 months, Yuyu Pharma, Inc. had revenue of 140.88B and earned 8.15B in profits. Earnings per share was 492.00.

In the last 12 months, operating cash flow was 14.89B and capital expenditures -10.69B, giving a free cash flow of 4.20B billion.

Yuyu Pharma, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Yuyu Pharma, Inc. upcoming earnings date is Aug 18, 2026, TBA (Confirmed).

Yuyu Pharma, Inc. as a current ratio of 1.64, with Debt / Equity ratio of 20.01%

In the past 12 months, Yuyu Pharma, Inc. has paid 365.96M in taxes.

Yuyu Pharma, Inc. EV to EBITDA ratio is 4.44, with an EV/FCF ratio of 9.44.

Yuyu Pharma, Inc. has ₩29.89B in cash and marketable securities with ₩26.21B in debt, giving a net cash position of ₩3.67B billion.

Gross margin is 37.88%, with operating margin of 7.82%, and net profit margin of 5.79%.

The average price target for Yuyu Pharma, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―